Developing and optimizing a chronic cyanotic swine model

J Surg Res. 2011 Nov;171(1):170-4. doi: 10.1016/j.jss.2010.03.004. Epub 2010 Mar 26.

Abstract

Background: Pulmonary artery (PA)-left atrial (LA) shunt models in piglets have been described, but technical details critical to limit morbidity/mortality and promote study of chronic cyanosis are lacking. Accordingly, we describe our experience with an optimized technique.

Materials and methods: In 25 6- to 8-wk-old Yorkshire piglets, a beveled, 8 mm, polytetrafluoroethylene tube graft was anastomosed to the PA and LA. Systemic pressure was maintained at >60 mmHg. Saturation targets were met by adjusting a Teflon band on the graft and distal PA. The target oxygen saturation (SO(2)) was 85% on a 50% fraction of inspired oxygen (FiO(2)). If the SO(2) was <75% on a 50% FiO(2), the graft was constricted to achieve a SO(2) ≥ 90% on a 100% FiO(2) and 75%-80% on a 21% FiO(2). Complications affecting mortality were neutralized with a stepwise strategy to minimize risk.

Results: Thrombosis, blood loss, and arrhythmia were determinants of survival. Protocol optimization over time increased survival while assuring chronic cyanosis. Survival approached 90%, with a SO(2) of 80% to 90%, 3 to 5 wk postoperatively. Complications included bleeding, excessive hypoxemia, uncontrolled shunt flow, arrhythmias, and thrombosis.

Conclusions: Refinement of surgical technique, shunt adjustment via graft banding, and thrombotic and arrhythmia prophylaxis are the keys to success with this model.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Anastomosis, Surgical
  • Animals
  • Arrhythmias, Cardiac / mortality
  • Arrhythmias, Cardiac / pathology
  • Biocompatible Materials
  • Chronic Disease
  • Cyanosis / mortality
  • Cyanosis / pathology*
  • Disease Models, Animal*
  • Heart Atria / pathology
  • Heart Defects, Congenital / mortality
  • Heart Defects, Congenital / pathology*
  • Hypoxia / pathology
  • Polytetrafluoroethylene
  • Pulmonary Artery / pathology
  • Sus scrofa*
  • Thrombosis / pathology

Substances

  • Biocompatible Materials
  • Polytetrafluoroethylene